Comparing GPT-4 and GPT-3.5: Examining the Difference

Date:

GPT-4 and GPT-3.5 are two of OpenAI’s natural language models and tools used for a variety of purposes, including natural language chatting and artificial intelligence. GPT-4 was trained on more data and is considered to be an upgrade from GPT-3.5, but how much better is it and what changes did OpenAI make? This article will dive into both models, their uses, and the differences between them.

GPT-3.5 and GPT-4 are both natural language models. GPT-3.5 was trained on 175 billions parameters, giving it the ability to produce human-like responses when given a prompt. GPT-4, however, was trained on much more data with over 1 trillion parameters, making it a major upgrade from its predecessor. GPT-4 was further trained on data from up to September 2021. In addition, OpenAI has added safeguards to the new model to make it safer and more secure, with their reports showing that GPT-4 is 82% less likely to respond to requests for disallowed content. GPT-4 also has a larger context window, up to 25,000 words, helping it to understand multiple details depending on the prompt it gets.

GPT-3.5 and GPT-4 both can be used to craft conversations or pass even complex, legal Bar exams. However, GPT-4 also had some exciting, creative features, such as the ability to craft an original story with believable and interesting characters. As well, it is more capable of understanding images, with some people using GPT-4 to generate recipe ideas based on pictures of their fridge or to even code a website based on a quick sketch.

If you want to use GPT-3.5 and GPT-4, you can access GPT-3.5 for free as part of ChatGPT, providing unlimited conversation as long as it isn’t too busy. On the other hand, accessing GPT-4 requires a ChatGPT Plus subscription, at a cost of $20 a month. Despite the extra cost, ChatGPT Plus provides extra advantages such as priority access when it is busy and the ability to use GPT-4 for free using Bing Chat.

See also  Massachusetts Hospitals, Doctors and Medical Groups Test ChatGPT Technology

OpenAI is one of the fastest-growing startups, focusing on artificial intelligence and natural language. Founded in 2015 and funded by some of the world’s largest tech companies, OpenAI’s mission is to ensure that it is safe and beneficial to use artificial intelligence. OpenAI rose to fame with the launch of GPT-3.0 and its latest GPT-4 is an even bigger achievement.

Finally, there is the founder of OpenAI, Sam Altman, who has been its President since 2015. The co-founder of Y Combinator is an entrepreneur, investor, and philanthropist, and Forbes lists him among the 400 wealthiest in the world. He has been continuing his work with OpenAI and pushing the boundaries of artificial intelligence.

In conclusion, GPT-4 is clearly a major upgrade from GPT-3.5 and OpenAI’s commitment to AI safety makes it a promising technology. Despite the cost for GPT-4, its huge storage capacity, longer context window and advanced programming capabilities make it worth the price. With OpenAI promising even more impressive developments in the future, it will be exciting to see what else they can do with the natural language model.

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.